Michael Soulen, MD of Hospital of the University of Pennsylvania discusses new data concerning PRRT at ASCO GI 2017.
Davendra Sohal, MD of Cleveland Clinic gives and update on the SWOG S1505 A randomized phase II study of perioperative…
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses what happens after NETTER-1 in Neuroendocrine Tumor research…
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses a poster he is presenting at ASCO GI…
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses the Phase III trial results of NETTER-1 as…
Bertram Wiedenmann, MD, PhD of Charité Universitätsmedizin Berlin? discusses the NETTER-1 results for patients with neuroendocrine tumors received an 18%…
Michael Hall, MD, MS of Fox Chase Cancer Center discusses how a tumors genetics may critically impact treatment options for…
Michael Hall, MD, MS of Fox Chase Cancer Center discusses the future of research and clinical trials in next generation…
Michael Hall, MD of Fox Chase Cancer Center discusses Emerging Technologies for Genetic Testing and in more detail Micro satellite…
Dr. Dale Shepard, MD of Cleveland Clinic gives an update on the The International Watch & Wait database (IWWD) for…
GRACE is pleased to present a series of webcasts with faculty member John Pagel, MD, PhD, DSc, from Swedish Cancer…
GRACE is pleased to present a series of webcasts with faculty member John Pagel, MD, PhD, DSc, from Swedish Cancer…
Daratumumab (DARA), a human CD38 IgG1? monoclonal antibody, has demonstrated single agent efficacy while being highly tolerable as a monotherapy,…
Dr. David Goodrich, Professor of Oncology at Roswell Park Cancer Institute, is co-author of a study offering new insights on…
Raúl Córdoba, MD, PhD, of University Hospital Fundación Jiménez DÃaz, Madrid, Spain, discusses his two main highlights from ASH 2016.…
Raúl Córdoba, MD, PhD, of University Hospital Fundación Jiménez DÃaz, Madrid, Spain, discusses results from a drugdrug interaction study (NCT02381080)…
Launched in July of 2016, SITC presents the newest in a series of videos focusing on immunotherapy for NSCLC patients,…
MPN expert Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center explains how doctors assess patients with…
Over the last 25 years, there has been an explosion of new and vitally important, anticancer drugs. The development of…
Patient Power,Andrew Schorr,Powerful Patients,medical interviews,interviews for patients,patient empowerment,breast cancer,Dr. William Gradishar,Robert H. Lurie Comprehensive Cancer Center,Northwestern University,San Antonio Breast Cancer…
In this Patient Power segment, Andrew Schorr talks with MPN experts Dr. Prithviraj Bose and Dr. Olatoyosi Odenike about the…
At the 2016 American Society of Hematology (ASH) meeting, Dr. Brian Walker of the University of Arkansas for Medical Sciences…
What is the latest news about lymphoma from ASH 2106? Lymphoma expert Dr. John Burke of Rocky Mountain Cancer Centers…
Dr Raajit Rampal, Memorial Sloan Kettering Cancer Center in New York City, interviews with David Wallace, PV Reporter. Discussing clinical…
Dr Jean Jacques Kiladjian, Professor of Clinical Hematology, Hopital Saint-Louis, Paris, France interviews with David Wallace, PV Reporter at ASH…
Tim Stockwell, PhD of University of Victoria, British Columbia, Canada gives an overview of his presentation focused on alcohols contribution…
Stan Kaye, BSc, MD, FRCP, FRCR, FRSE, FMedSci of Royal Marsden NHS Foundation Trust, London, UK discusses drug resistance in…
Robert Coleman, MBBS, MD, FRCP, FRCPE of Sheffield Cancer Research, University of Sheffield, UK discusses issues with drug repurposing. Most…
Linda Bauld, PhD of the University of Stirling, UK discusses as session on the prevention of cancer at the population…
Elena Semino, PhD of Lancaster University, UK, discusses findings from research on how language can affect patients with cancer. There…
Cheng-Har Yip, MB, BS, FRCS of Breast Surgery International, Malaysia discusses the challenges in the management of breast cancer in…
Elaine Vickers, BMedSc, PhD of Science Communicated Ltd, Sheffield, UK gives an overview of sessions, which introduce an audience to…
Elena Semino, PhD, of Lancaster University, UK, provides an overview of a session on ‘How we talk about cancer’, which…
Keith McCrae, MD of Cleveland Clinic discusses the current treatment trends for non-malignant hematology at the 58th ASH Annual Meeting…
Keith McCrae, MD of Cleveland Clinic gives his view on pomalidomide in HHT care at the 58th ASH Annual Meeting…
Keith McCrae, MD of Cleveland Clinic discusses how patients with HHT disorder respond well to pomalidomide treatment at the 58th…
Jason Valent, MD of Cleveland Clinic discusses the 5 year outlook of plasma cell therapy in multiple myeloma at the…
Jason Valent, MD of Cleveland Clinic gives an overview of the current treatment trends for amyloidosis at the 58th ASH…
Jason Valent, MD of Cleveland Clinic talks about daratumumab in multiple myeloma at the 58th ASH Annual Meeting in San…
Jason Valent, MD of Cleveland Clinic discusses how new novel agents are changing the management of amyloidosis at the 58th…
Jason Valent, MD of Cleveland Clinic discusses how NEOD001 leads to clinical trials at the 58th ASH Annual Meeting in…
Jason Valent, MD of Cleveland Clinic discusses specific novel drugs that break down amyloid fibrils at the 58th ASH Annual…
David Miklos, MD, PhD of Stanford University Medical Center discusses the big news surrounding ibrutinib for Graft-versus-Host Disease at the…
David Miklos, MD, PhD of Stanford University Medical Center, discusses ibrutinib in Chronic Graft-versus-Host Disease at the 58th ASH Annual…
David Miklos, MD, PhD of Stanford University Medical Center, gives an overview of his abstract, Allogeneic Transplants from HLA-Mismatched Unrelated…
Jonathan Gerber, MD of Levine Cancer Institute discusses a novel approach from a translational research project in identifying stem cell…
Jonathan Gerber, MD of Levine Cancer Institute, discusses advances in research and treatment trends for AML at the 58th ASH…
Jonathan Gerber, MD of Levine Cancer Institute, gives an overview of a clinical study that shows pembrolizumab is active in…
Jonathan Gerber, MD of Levine Cancer Institute, talks about how targeting leukemia stem cell population may cure AML overall at…
Anne Neff, MD of Cleveland Clinic, gives an overview of the upcoming treatment trends for bleeding disorders in 2017 at…
Anne Neff, MD of Cleveland Clinic talks about how new research in hemophilia will impact clinical practitioners at the 58th…
Anne Neff, MD of Cleveland Clinic discusses how to prevent hemophilia from pain and functional impairment at the 58th ASH…
Anne Neff, MD of Cleveland Clinic, gives an overview of her abstract, Linear and Logistic Regression Models of Patient-Reported Outcomes…
Is there such thing as treatment-free remission for a CML patient? CML expert Dr. Jessica Altman of Robert H. Lurie…
What is the latest in myeloproliferative neoplasms (MPNs) from the American Society of Hematology (ASH) annual meeting and what does…
Dr. Copelan, Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, discusses which ASH 2016 presentations were the…
Dr. Copelan, Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, on how he reduced the number of…
Dr. Copelan, Chair, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, talks about his Levine Cancer Institute program
Robert G. Uzzo, M.D. Willing G. Pepper Chairman of Surgery Fox Chase Cancer Center Temple University School of Medicine Chair,…
Paul Barr, MD gives his opinion on what will change in CLL treatment and therapy in the longterm at the…
Paul Barr, MD of University of Rochester gives an overview of the current trends and strategies in CLL treatment at…
Paul Barr, MD of University of Rochester, discusses data from the Resonate-2 Study at the 58th ASH Annual Meeting in…
Paul Barr, MD of University of Rochester, discusses how promising ibrutinib is as a first line treatment for older patients…
Paul Barr, MD of University of Rochester, discusses the use of ibrutinib in combination therapy from Resonate-2 Study at the…
Paul Barr, MD of University of Rochester, gives an overview of a clinical trial, Updated Efficacy and Safety from the…
David M. Foureau, PhD of Levine Cancer Institute gives an overview of the current trends for therapy in myeloma at…
MPN expert Dr. Srdan Verstovsek of MD Anderson Cancer Center shares a comprehensive overview of the treatments for myeloproliferative neoplasms…
David M. Foureau, PhD of Levine Cancer Institute, talks about new and interesting data from myeloma study that was presented…
David M. Foureau, PhD of Levine Cancer Institute gives an overview of his abstract, Peripheral Immune Profile and Minimal Residual…
David M. Foureau, PhD of Levine Cancer Institute discusses targeted therapies for myeloma patients at the 58th ASH Annual Meeting…
David M. Foureau, PhD of Levine Cancer Institute discusses how targeting T-cells in myeloma may be the new focus for…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin discusses the exciting new data in myeloma treatment that has…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin gives his view on the outlook and future of treatments,…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin talks about how the StaMINA trial will impact future clinical…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin discusses the recent trend of immunotherapy in transplantation in myeloma…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin discusses a new standard of care for newly diagnosed myeloma…
Parameswaran Hari, MD, MRCP, MS of Medical College of Wisconsin gives an overview of the results and aftermath of Phase…
Alok Khorana, MD of Cleveland discusses the importance of assessing for risks of clots and bleeding before administering medication at…
Alok Khorana, MD of Cleveland Clinic discusses how new and important data on direct oral anticoagulants, which is widely used…
Alok Khorana, MD of Cleveland Clinic, discusses how recent funding for thromboprophylaxis may lead to a clinical trial that will…
Alok Khorana, MD of Cleveland Clinic discusses the recent transition from injectable anticoagulants, which is sometimes difficult to manage, to…
Is interferon or hydroxyurea (Hydrea) more effective as a treatment for polycythemia vera (PV)? MPN expert and researcher, Dr. Heinz…
Can CML patients responding positively to therapy have their medications safely reduced? CML expert Dr. Mhairi Copland of the University…
Alok Khorana, MD of Cleveland Clinic discusses a cohort study that focused on bleeding predictors in hospitalized cancer patients at…
Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses several and recent developments in AML treatment at the 58th ASH Annual…
Sudipto Mukherjee, MD, MPH of Cleveland Clinic discusses how the new drug, eltrombopag, works safely and more effectively for patients…
Sudipto Mukherjee, MD, MPH of Cleveland Clinic gives an overview of his abstract: A Single Arm, Phase II Study of…
Yogenthiran Saunthararajah, MD of Cleveland Clinic discusses potential and non-toxic treatments for Sickle Cell Disease at the 58th ASH Annual…
Yogenthiran Saunthararajah, MD of Cleveland Clinic, discusses the current updates and trends surrounding treatment in Sickle Cell Disease at the…
Yogenthiran Saunthararajah, MD of Cleveland Clinic gives an overview of his abstract, Phase 1 Evaluation of Oral Tetrahydrouridine-Decitabine As Non-Cytotoxic…
Brian Hill, MD, PhD of Cleveland Clinic discusses the possibility of a combination between checkpoint inhibitors and CAR T-Cell therapy…
Brian Hill, MD, PhD of Cleveland Clinic discusses the important role of checkpoint inhibitors in Richter’s Transformation treatment at the…
Brian Hill, MD, PhD of Cleveland Clinic, gives an overview of the updates surrounding CLL treatments, specifically how CAR T-Cell…
Brian Hill, MD, PhD, of Cleveland Clinic discusses how Venetoclax may be the best novel agent for patients who are…
Brian Hill, MD, PhD, of Cleveland Clinic discusses updates surrounding CLL, specifically responses to Ibrutinib and Venetoclax as the optimal…
Navneet Majhail, MD of Cleveland Clinic, discusses how TP53 mutations lead to poor overall survival in patients with MDS at…
Navneet Majhail, MD, of Cleveland Clinic, discusses the importance of genetic alterations and mutation profiles of patients that are undergoing…
Navneet Majhail, MD of Cleveland Clinic, gives an overview of Abstract 69: Genetic Alterations Predict Outcomes in Patients with Myelodysplastic…
Jasmine Micklem, PhD, of the South Australian Health and Medical Research Institute, Adelaide, Australia, and Roslyn Weetra, an Aboriginal Elder…
Bernardo Rapoport, MD of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discusses side effects associated with different types…
Charles Kamen, PhD of University of Rochester Medical Center, Rochester, NY discusses the impact of dyadic exercises on cancer patients.…
Jennifer Brown, MD of Dana Farber, discusses a current and promising trial that combines ibrutinib with a standard chemo-immunotherapy combination:…
Jennifer Brown, MD of Dana Farber, discusses a promising study that combines Ibrutinib with TGR-1202 and its results at the…
Jennifer Brown, MD of Dana Farber, discusses the update of the 5 year data from the Ibrutinib study at the…
Jennifer Brown, MD of Dana Farber, gives an overview of the latest treatment trends for CLL for the upcoming year…
Jennifer Brown, MD of Dana Farber discusses the updates of CAR T-Cell Therapy in CLL from the 58th ASH Annual…
Steven T. Rosen, MD of City of Hope, discusses the use of novel strategies for stem cell efficacy versus its…
Steven T. Rosen, MD of City of Hope, discusses the potential of leflunomide for multiple myeloma at the 58th ASH…
Steven T. Rosen, MD of City of Hope, gives an overview of the current trials on stem cell research for…
Susan M. O’Brien, MD of University of California Irvine, discusses the future of clinical trials for ibrutinib that may result…
Susan M. O’Brien, MD of University of California Irvine, discusses possible drug holidays and combination therapy for CLL at the…
Susan M. O’Brien, MD of University of California Irvine gives an overview of the updates in combination therapy for CLL…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives a shoutout to his grandma and grandpa at the 58th ASH…
Joshua Brody, MD, PhD of Mount Sinai Hospital, discusses how to rationally combine immunotherapies for patients with lymphoma by increasing…
Joshua Brody, MD, PhD of Mount Sinai Hospital, discusses the GALLIUM Trial and advances in immunotherapy for lymphoma at the…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an update on CAR T-Cell Lymphoma data from the 58th ASH…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, discusses how animal studies closely resemble clinical trial results in combining in…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, discusses his abstract on Combining In Situ Vaccination with Immune Checkpoint Blockade…
Joshua Brody, MD, PhD, of Mount Sinai Hospital, gives an overview of a clinical trial by Dana Farber that shows…
Peter Hillmen from St. James University Hospital, Leeds, UK introduces the 17th International Workshop on chronic lymphocytic leukemia (iwCLL), which…
Stephen Sonis, DMD, DMSc of Brigham and Women’s Hospital, Boston, MA discusses costs of cancer care. The cost of new…
Michael Brown, MBBS, FRACP, FRCPA of Royal Adelaide Hospital, Adelaide, Australia discusses global immune checkpoint inhibitor studies. Prof Brown mentions…
Jervoise Andreyev, MA, PhD, FRCP of The Royal Marsden NHS Foundation Trust, London, United Kingdom talks about MASCC discussions focused…
Jasmine Micklem, PhD, of the South Australian Health and Medical Research Institute, Adelaide, Australia, discusses disparities in the incidence of…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa talk…
Meera Agar, MBBS, MPC, FRACP, PhD of University of Technology Sydney, Sydney, Australia discusses delirium treatment options. The guidelines internationally…
Matthew Ciorba, MD of Washington University School of Medicine in St. Louis, St. Louis, MO discusses how to use probiotics…
Jean Klastersky, MD, PhD of Institut Jules Bordet, Brussels, Belgium summarises key messages from the MASCC 2016 session focused on…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discuss…
Roslyn Weetra, an Aboriginal Elder and cancer survivor, discusses her experience with cancer being a member of the Australian aboriginal…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa give…
Gordon Howarth, PhD of The University of Adelaide, Adelaide, Australia discusses mucositis with a focus on probiotics screening system. Mucositis…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa talk…
Susan M. O’Brien, MD of University of California Irvine, gives an overview of Abstract 233: Five-Year Experience with Single-Agent Ibrutinib…
Susan M. O’Brien, MD of University of California Irvine, gives an overview of Five-Year Experience with Single-Agent Ibrutinib in Patients…
As part of our 2016 American Society of Hematology (ASH) annual meeting coverage, MPN experts Dr. Catriona Jamieson, Dr. John…
Doctors and Healthcare Professionals answer questions at the Press Briefing Q&A: Improved Outcomes in Leukemia, Trauma Settings with Personalized Medicine…
Francois-Xavier Mahon, MD, PhD of University of Bordeaux, presents a press briefing on Cessation of Tyrosine Kinase Inhibitors Treatment in…
Evi X. Stavrou, MD of Case Western Reserve University, presents a press briefing on Miniaturized Microfluidic Dielectric Sensor for Point-of-Care…
Mhairi Copland, BSc (Hons) MB ChB PhD FRCP FRCPath of the University of Glasgow, presents a press briefing of Chronic…
Harry P. Erba, MD, PhD of the University of Alabama at Birmingham School of Medicine, presents a press brief on…
Julie Jaffray, MD of Children’s Hospital Los Angeles, presents a press brief on Determining the Incidence and Risk Factors for…
Mikkael Sekeres, MD, MS of Cleveland Clinic, introduces the press briefing to Improved Outcomes in Leukemia, Trauma Settings with Personalized…
Doctors and Healthcare Professionals answer questions at the Press Briefing Q&A: Developing Novel Therapies and Unique Delivery Methods to Improve…
Terry J. Fry, MD of National Cancer Institute, presents a press brief on Minimal Residual Disease Negative Complete Remissions Following…
Katherine A. High, MD of Spark Therapeutics, presents a press briefing on Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia…
Allan Doctor, MD of Washington University School of Medicine in St. Louis, presents Erythromer (EM), a Nanoscale Bio-Synthetic Artificial Red…
Caroline E. Hansen, BS of Georgia Institute of Technology presents Leveraging the Contractile Force of Platelets for Targeted Factor VIII…
Jeffrey E. Lancet, MD of Moffitt Cancer Center presents Survival Following Allogeneic Hematopoietic Cell Transplantation in Older High-Risk Acute Myeloid…
Dr. Armand Keating, MD, FRCP(C), Director, Cell Therapy Program and Philip S. Orsino Facility for Cell Therapy, Princess Margaret Hospital/Ontario…
Stephen Sonis, DMD, DMSc of Brigham and Women’s Hospital, Boston, MA discusses cancer supportive care and its importance for cancer…
Phyllis Butow, BA (Hons), Dip Ed, MClinPsych, MPH, PhD of The University of Sydney, Sydney, Australia talks about a family…
Michael Brown, MBBS, FRACP, FRCPA of Royal Adelaide Hospital, Adelaide, Australia discusses side effects associated with immune checkpoint inhibitors. For…
Mette Marcussen, DDS, PhD of Aalborg University Hospital, Aalborg, Denmark discusses studies focused on identification of mucositis biomarkers. Biopsies from…
Matthew Ciorba, MD of Washington University School of Medicine in St. Louis, St. Louis, MO discusses mucositis prevention using probiotics.…
Jean Klastersky, MD, PhD of Institut Jules Bordet, Brussels, Belgium talks about the severity of side effects associated with immune…
Ian Hewson, BDSc, FICD, FADI, FPFA of Alfred Hospital, Melbourne, Australia talks about his treatment journey after being diagnosed with…
Gordon Howarth, PhD of The University of Adelaide, Adelaide, Australia talks about probiotics and the way they are perceived. Unlike…
David Currow, BMed, PhD, MPH, FRACP, FAChPM, FAHMS, GAICD of Flinders University, Adelaide, Australia, discusses delirium in cancer patients. Patients,…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discuss…
Rachel Gibson, PhD of University of South Australia, Adelaide, Australia, discusses the role of gut microbiome in causing diarrhea in…
Phyllis Butow, BA (Hons), Dip Ed, MClinPsych, MPH, PhD of The University of Sydney, Sydney, Australia discusses teaching communication skills…
Matthew Ciorba, MD of Washington University School of Medicine in St. Louis, St. Louis, MO discusses how microbes can modify…
Jean Klastersky, MD, PhD of Institut Jules Bordet, Brussels, Belgium gives an overview of a session focused on geriatric assessment.…
Jean Klastersky, MD, PhD of Institut Jules Bordet, Brussels, Belgium discusses adverse effects associated with immune checkpoint inhibitors. Prof Klastersky…
Ian Hewson, BDSc, FICD, FADI, FPFA of Alfred Hospital, Melbourne, Australia discusses his experiences after being diagnosed with low grade…
Gordon Howarth, PhD of The University of Adelaide, Adelaide, Australia discusses complementary therapies for patients with mucositis. The role of…
Giovanni Rosti, MD of Ospedale Generale, Treviso, Italy highlights key discussion points from MASCC 2016. New drugs help to reduce…
David Currow, BMed, PhD, MPH, FRACP, FAChPM, FAHMS, GAICD of Flinders University, Adelaide, Australia, discusses chronic breathlessness in cancer patients.…
Bernardo Rapoport, MD and Ronwyn Van Eeden MBChB, FCP(SA) of The Medical Oncology Centre of Rosebank, Johannesburg, South Africa discuss…
Alex Molassiotis, RN, MSc, PhD of The Hong Kong Polytechnic University, Hong Kong, discusses personalized treatments for nausea and vomiting.…
Patient Power Founder Andrew Schorr and MPN world expert Dr. Srdan Verstovsek of the University of Texas MD Anderson Cancer…
In this Ask the Expert segment, Dr. Ruben Mesa from Mayo Clinic responds to a Patient Power community member’s question…
Afaf Girgis, PhD, of the University of New South Wales, Sydney, Australia, discusses the importance of psycho-oncology at the 2016…
Robert Coleman, MBBS, MD, FRCP, FRCPE of Sheffield Cancer Research, University of Sheffield, UK gives an overview of a debate…
Lieping Chen, MD, PhD of Yale School of Medicine, New Haven, CT discusses two approaches to cancer immunotherapy. Immune system…
Corinne Faivre-Finn, FRCR, MD, PhD of University of Manchester and the Christie NHS Foundation Trust, UK discusses key messages from…
Karen Mustian, PhD, MPH, ACSM of the University of Rochester Medical Center, Rochester, New York, NY highlights the importance of…
Alex Molassiotis, RN, MSc, PhD of The Hong Kong Polytechnic University, Hong Kong, discusses nausea and vomiting risk factors. Clinicians…
David Currow, BMed, PhD, MPH, FRACP, FAChPM, FAHMS, GAICD of Flinders University, Adelaide, Australia, discusses challenges in cancer supportive care.…
Paolo Bossi, MD of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy summaries the important messages to take away from…
Douglas Peterson, DMD, PhD, FDS RCSEd of UConn Health, Farmington, CT discusses management techniques allied to help treat symptom clusters.…
David Hui, MD, MSc of MD Anderson Cancer Center, Houston, TX discusses end-of-life decisions faced by a clinical team. Understanding…
Winston Tan, MD of Mayo Clinic, Jacksonville, FL discusses a treatment of bone metastases in prostate cancer. Dr Tan mentions…
Paolo Bossi, MD of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy discusses the role of probiotics in gut mucositis,…
Irma Verdonck-de Leeuw, PhD of VU University Medical Center, Amsterdam, The Netherlands discusses online intervention approaches to treat insomniac cancer…
Douglas Peterson, DMD, PhD, FDS RCSEd of UConn Health, Farmington, CT discusses working towards a better understanding as to why…
David Currow, BMed, PhD, MPH, FRACP, FAChPM, FAHMS, GAICD of Flinders University, Adelaide, Australia, discusses anamorelin in ROMANA 1 and…
Alex Molassiotis, RN, MSc, PhD of The Hong Kong Polytechnic University, Hong Kong discusses focus on nausea and vomiting together,…
Afaf Girgis, PhD, of the University of New South Wales, Sydney, Australia talks about ways to make unmet needs easier…
Lieping Chen, MD, PhD of Yale School of Medicine, New Haven, CT discusses future directions in cancer treatment. Thanks to…
Alex Mitchell, MBBS, BMedSci, MSc, MD, MCPsyc, of the University of Leicester, UK, discusses the next steps for screening programs…
Lieping Chen, MD, PhD of Yale School of Medicine, New Haven, CT discusses the PD-1/PD-L1 molecular pathway. The two molecules…
Corinne Faivre-Finn, FRCR, MD, PhD of University of Manchester and the Christie NHS Foundation Trust, UK discusses next steps for…
Afaf Girgis, PhD, of the University of New South Wales, Sydney, Australia, discusses unmet needs for cancer patients and care…
Lieping Chen, MD, PhD of Yale School of Medicine, New Haven, CT gives an overview of his talk on PD-1/PD-L1…
Corinne Faivre-Finn, FRCR, MD, PhD of University of Manchester and the Christie NHS Foundation Trust, UK, gives an overview of…
Alex Mitchell, MBBS, BMedSci, MSc, MD, MCPsyc, of the University of Leicester, UK, gives an overview of his talk on…
Afaf Girgis, PhD, of the University of New South Wales, Sydney, Australia, gives an overview of her talk on unmet…
Giovanni Rosti, MD of Ospedale Generale, Treviso, Italy discusses a study focused on ex-patients after the standard 5-year follow-up period…
Gregory Crawford, MBBS, MPHC, MD, FRACGP, FAChPM of The University of Adelaide, Adelaide, Australia discusses how to handle end of…
Irma Verdonck-de Leeuw, PhD of VU University Medical Center, Amsterdam, The Netherlands discusses sleep disturbances and supportive care approaches. There…
Jeeve Kanagalingam, MD of Mount Elizabeth Novena Hospital, Singapore, discusses oral mucositis investigations. Looking at patient and physician perspectives of…
Paolo Bossi, MD of Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy discusses a MASCC 2016 workshop focused on mucositis…
Winston Tan, MD of Mayo Clinic, Jacksonville, FL discusses the impact of cancer on the bone micro-environment. Bone metastasis is…
Antonio Llombart, MD, PhD, of the University Hospital Arnau de Vilanova, Valencia, Spain, discusses physical exercise to help lower the…
Antonio Llombart, MD, PhD, of the University Hospital Arnau de Vilanova, Valencia, Spain, discusses extended endocrine therapy for the prevention…
Julia Camps Herrero, MD of the Hospital de la Ribera, Alzira, Spain, discusses the use of various methods for the…
Katy Hogben, MBBS, FRCS, PhD, talks about when and in what cases radiotherapy is used for the treatment of breast…
Antonio Llombart, MD, PhD, of the University Hospital Arnau de Vilanova, Valencia, Spain, discusses two trials, the SOFT and TEXT…
Mafalda Oliveira, MD of the Vall d’Hebron University Hospital, Barcelona, Spain discusses her talk on the results of the Phase…
Wolfgang Janni, MD, PhD, of the University of Ulm, Ulm, Germany, talks about his side of the debate of whether…
Peter Schmid, FRCP, MD, PhD of the Barts Cancer Institute, London, UK, talks about recent studies where platinum compounds are…
Pierfranco Conte, MD of the University of Padova, Padova, Italy talks about his side of the debate on whether or…
Laura Esserman, MD, MBA, of the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA talks about neoadjuvant therapy…
Katy Hogben, MBBS, FRCS, PhD, of Imperial College Healthcare, London, UK discusses the importance of MRI at the 2016 World…
Julia Camps Herrero , MD of the Hospital de la Ribera, Alzira, Spain, discusses the use of MRI for the…
Bruce Mann, MBBS, PhD, FRACS, of the Peter MacCallum Cancer Centre, Victoria, Australia, talks about the World Congress on Controversies…
Antonio Llombart, MD, PhD, of the University Hospital Arnau de Vilanova, Valencia, Spain, discusses new combination treatments for patients with…
Is it recommended that all MPN patients be on a cholesterol-lowering medication? Dr. Olatoyosi Odenike from the University of Chicago…
Whats the best way to access genetic testing? Is it necessary? Is it expensive? Does insurance cover the costs? Experts…
What is the expected life span and quality of life for a patient diagnosed with essential thrombocythemia (ET)? In this…
Do the new PV (polycythemia vera) medications such as JAK2 inhibitors benefit patients that do not have a spleen? Dr.…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, discusses the treatments of elderly chronic lymphocytic leukemia (CLL) patients…
Stephan Stilgenbauer, MD, PhD of Ulm University, Ulm, Germany, discusses the development of drugs for treatment in chronic lymphocytic leukemia…
Anna Schuh, MD, PhD, MRCP, FRCPath of University of Oxford, Oxford, UK, discusses new developments in the field of precision…
Julia von Tresckow, MD of University of Cologne, Cologne, Germany, discusses the CLL2-BIG trial, which is one of four trials…
Clemens Wendtner, MD of Klinikum Schwabing, Munich, Germany, highlights key advances in the field of chronic lymphocytic leukemia (CLL) discussed…
Barbara Eichhorst, MD of the University of Cologne, Cologne, Germany, how to take care of the mental well-being of chronic…
World-renowned MPN expert Dr. Ruben Mesa of Mayo Clinic discusses the recently updated NCCN guidelines that help advise doctors around…
In this video, Drs. Morton Coleman and John P. Leonard summarize the key take-home points presented on lymphoma during Lymphoma…
In this video, Drs. Morton Coleman and Richard R. Furman summarize the key take-home points presented on CLL during Lymphoma…
In this video Drs. Morton Coleman and Ruben Niesvizky summarize the key take-home points presented on multiple myeloma during Lymphoma…
Raquibul Hannan, MD Radiation Oncologist, University of Texas Southwestern discusses SABR and immunotherapy.
Raquibul Hannan, MD Radiation Oncologist, University of Texas Southwestern discusses Utilizing SABR in the oligo-metastatic disease.
Raquibul Hannan, MD Radiation Oncologist, University of Texas Southwestern discusses SABR in locally advanced RCC and oligo-metastatic disease.
Raquibul Hannan, MD Radiation Oncologist, University of Texas Southwestern discusses What is the role of SABR in CNS mets in…
Eric Jonasch, MD of MD Anderson gives an overview of several presentations covering the Understanding Molecular Subtypes of Non-Clear Cell…
Chung-Han Lee, MD, PhD, Medical Oncologist, Memorial Sloan Kettering interview on Medullary Renal Cell Carcinoma (RCC): Genomics and Treatment Outcomes.
Ithaar H. Derweesh, M.D., University of California, San Diego discusses neoadjuvant therapy for patients with metastatic disease and extra renal…
Ithaar H. Derweesh, M.D., University of California, San Diego discusses the historical data for neoadjuvant therapy in RCC.
Guru Sonpavde, MD, Associate Professor of Medicine Director, Urologic Oncology, UAB Comprehensive Cancer Center notes that More Single Agent Therapy…
Guru Sonpavde, MD, Associate Professor of Medicine Director, Urologic Oncology, UAB Comprehensive Cancer Center discusses VEGF followed by PD-1 inhibition…
Guru Sonpavde, MD, Associate Professor of Medicine Director, Urologic Oncology, UAB Comprehensive Cancer Center answers the question Why would sequencing…
David McDermott, MD of Dana Farber discusses toxicity concerns with the combination VEGF PD-1.
David McDermott, MD of Dana Farber answers the question Why VEGF + PD-1 are logical choices for combination therapy in…
Naomi B. Haas, MD, Director, Prostate and Kidney Cancer Program, Associate Professor of Medicine at the Hospital of the University…